世界の体外受精市場2021-2028:機器別(使い捨てデバイス、培地)、処置タイプ別(新鮮ドナー、凍結ドナー)、最終用途別、地域別

◆英語タイトル:In-vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Donor, Frozen Donor), By End-use, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MA049
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の体外受精市場規模が2028年までに339憶ドルに達すると予測しています。2021年から2028年までに年平均6.5%成長する見通しです。本調査レポートでは、体外受精の世界市場について広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、種類別(新鮮ノンドナー、凍結ノンドナー、新鮮ドナー、凍結ドナー)分析、最終用途別(不妊治療クリニック、病院・その他)分析、機器別(培地、使い捨てデバイス、主要機器)分析、地域別分析、競争分析など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・体外受精の世界市場規模:種類別(新鮮ノンドナー、凍結ノンドナー、新鮮ドナー、凍結ドナー)
・体外受精の世界市場規模:最終用途別(不妊治療クリニック、病院・その他)
・体外受精の世界市場規模:機器別(培地、使い捨てデバイス、主要機器)
・体外受精の世界市場規模:地域別
・競争分析
【レポートの概要】

In-vitro Fertilization Market Growth & Trends

The global in-vitro fertilization market size is expected to reach USD 33.9 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The growth of the market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during In Vitro Fertilization (IVF) is further expected to drive the market. The insurance providers are providing coverage to IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors such as a behavioral shift in society. These factors include a shift from rural to urban societies, the increased age of the first birth, an increasing number of women in the labor force, postponement of marriage, and lower marriage rates.

The in-person fertility treatments in U.S. and Canada were suspended in March 2020 by the Canadian Fertility and Andrology Society and American Society of Reproductive Medicine due to the COVID-19. However, treatment is resuming in many countries with ease of COVID-19 restrictions, including the developing nations. Medicover Fertility, IVF center in India, in July 2020 announced to resume the IVF procedures after initial COVID risk assessment.

In-vitro Fertilization Market Report Highlights

• Culture media dominated the market for IVF in terms of revenue in 2020. A number of research activities are being undertaken to improve the efficiency of culture media. For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery and sperm-hyaluronic acid-binding

• Europe dominated the market for IVF in 2020. Adoption of advanced technologies such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards contribute to market growth in the region

• The APAC region is expected to witness increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle

• The developing countries in Asia Pacific are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy

• In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Procedure
1.1.2 End-use
1.1.3 instrument
1.1.4 Regional Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 VOLUME PRICE ANALYSIS
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Procedure
2.2.2 End-use
2.2.3 Instrument
2.2.4 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Analysis
3.4 Clinical Trials
3.5 User Perspective Analysis
3.5.1 Consumer Behavior Analysis
3.5.2 Market Influencer Analysis
3.6 Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Rising reprotourism
3.6.1.2 Technological advancements in IVF
3.6.1.3 Favorable government funding
3.6.1.4 Late initiation of family
3.6.1.5 Increasing incidence rate of male and female infertility
3.6.1.6 Mergers and acquisitions (M&A)
3.6.2 Market restraint analysis
3.6.2.1 High cost of IVF treatment
3.6.2.2 Lack of regulatory framework and uniform regulations
3.6.2.3 Vulnerability of women depending on cross-border reprotourism market
3.7 Business Environment Analysis Tools
3.7.1 Porter’s five forces analysis
3.7.1.1 Bargaining power of buyers: Low
3.7.1.2 Bargaining power of suppliers: Moderate
3.7.1.3 Competitive rivalry: High
3.7.1.4 Threat of new entrants: Moderate
3.7.1.5 Threat of substitutes: Low
3.7.2 SWOT Analysis, by PESTEL
3.7.2.1 Political & legal
3.7.2.2 Economic
3.7.2.3 Technological
3.7.3 Major Deals & Strategic Alliances Analysis
3.7.3.1 Joint ventures
3.7.3.2 Mergers & acquisitions
3.7.4 Qualitative Analysis: Impact of COVID-19 on IVF Market
3.7.5 Impact of COVID-19 Pandemic: Country Analysis
3.7.5.1 U.S.
3.7.5.2 Canada
3.7.5.3 U.K.
3.7.5.4 Germany
3.7.5.5 France
3.7.5.6 Spain
3.7.5.7 Italy
3.7.5.8 Netherlands, Switzerland, and Belgium
3.7.5.9 Japan
3.7.5.10 India
3.7.5.11 China
3.7.5.12 Brazil
3.7.5.13 Mexico
3.7.5.14 South Africa
Chapter 4 In Vitro Fertilization Market: Type Analysis
4.1 In Vitro Fertilization by Type Market Share Analysis, 2020 & 2028
4.2 Segment Dashboard
4.3 Global In Vitro Fertilization Procedures Market, by Type, 2016-2028
4.4 Market Size and Forecasts and Trend Analysis, 2016-2028 for the Type
4.4.1 Fresh nondonor
4.4.1.1 Fresh nondonor market, 2016-2028 (USD Million)
4.4.2 Frozen nondonor
4.4.2.1 Frozen nondonor market, 2016-2028 (USD Million)
4.4.3 Fresh donor
4.4.3.1 Fresh donor market, 2016-2028 (USD Million)
4.4.4 Frozen donor
4.4.4.1 Frozen donor market, 2016-2028 (USD Million)
Chapter 5 In Vitro Fertilization Market: End-use Analysis
5.1 In Vitro Fertilization End-use Market Share Analysis, 2020 and 2028
5.2 Segment Dashboard
5.3 Market Size and Forecasts and Trend Analysis, 2016-2028 for the Following End-Use
5.3.1 Fertility clinics
5.3.1.1 Fertility clinics market, 2016-2028 (USD Million)
5.3.2 Hospitals and other settings
5.3.2.1 Hospitals and other settings market, 2016-2028 (USD Million)
Chapter 6 In Vitro Fertilization Market: Instrument Analysis
6.1 In Vitro Fertilization (IVF) Market Share analysis, 2020 & 2028
6.2 Segment Dashboard
6.3 Global IVF Market, by Instrument, 2020 to 2028
6.4 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the Instrument:
6.4.1 Culture media
6.4.1.1 Culture media market, 2016 – 2028 (USD Million)
6.4.2 Disposable devices
6.4.2.1 Disposable devices market, 2016-2028 (USD Million)
6.4.3 Capital equipment
6.4.3.1 Capital equipment market, 2016-2028 (USD Million)
Chapter 7 Regional Outlook
7.1 Regional market share analysis, 2020 & 2028
7.2 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.3 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Latin America
7.3.5 MEA
7.4 List of Few Fertility Clinics
7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific
7.4.4 Latin America
7.4.5 MEA
7.5 Market Size, & Forecasts and Trend Analysis, 2020 to 2028
7.5.1 North America
7.5.1.1 North America Ivf market, 2016 – 2028 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. IVF market, 2016 – 2028 (USD Million)
7.5.1.3 Canada
7.5.1.3.1 Canada IVF market, 2016 – 2028 (USD Million)
7.5.2 Europe
7.5.2.1 Europe IVF market, 2016 – 2028 (USD Million)
7.5.2.2 France
7.5.2.2.1 France IVF market, 2016 – 2028 (USD Million)
7.5.2.3 Germany
7.5.2.3.1 Germany IVF market, 2016 – 2028 (USD Million)
7.5.2.4 Italy
7.5.2.4.1 Italy IVF market, 2016 – 2028 (USD Million)
7.5.2.5 Spain
7.5.2.5.1 Spain IVF market, 2016 – 2028 (USD Million)
7.5.2.6 U.K.
7.5.2.6.1 U.K. IVF market, 2016 – 2028 (USD Million)
7.5.2.7 Belgium
7.5.2.7.1 Belgium IVF market, 2016 – 2028 (USD Million)
7.5.2.8 Netherlands
7.5.2.8.1 Netherlands IVF market, 2016 – 2028 (USD Million)
7.5.2.9 Switzerland
7.5.2.9.1 Switzerland IVF market, 2016 – 2028 (USD Million)
7.5.3 Asia Pacific
7.5.3.1 Asia Pacific IVF market, 2016 – 2028 (USD Million)
7.5.3.2 Japan
7.5.3.2.1 Japan IVF market, 2016 – 2028 (USD Million)
7.5.3.3 China
7.5.3.3.1 China IVF market, 2016 – 2028 (USD Million)
7.5.3.4 India
7.5.3.4.1 India IVF market, 2016 – 2028 (USD Million)
7.5.4 Latin America
7.5.4.1 Latin America IVF market, 2016-2028 (USD Million)
7.5.4.2 Brazil
7.5.4.2.1 Brazil IVF market, 2016-2028 (USD Million)
7.5.4.3 Mexico
7.5.4.3.1 Mexico IVF market, 2016-2028 (USD Million)
7.5.5 Middle East & Africa
7.5.5.1 MEA IVf market, 2016-2028 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa IVf market, 2016-2028 (USD Million)
Chapter 8 Competitive Analysis
8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
8.2 Vendor Landscape
8.2.1 Strategy Mapping
8.2.2 Launch of New Products
8.2.3 Merger and Acquisition
8.2.4 Product Approvals
8.2.5 Partnerships
8.2.6 Marketing & Promotions
8.3 Company Market Position Analysis
8.4 Company Profiles
8.4.1 OvaScience, Inc.
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.1.5 SWOT analysis
8.4.2 Vitrolife AB (publ)
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.2.5 SWOT analysis
8.4.3 emd serono, inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.3.5 SWOT analysis
8.4.4 FUJIFILM Irvine Scientific
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.4.5 SWOT analysis
8.4.5 The Cooper Companies, Inc.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.5.5 SWOT analysis
8.4.6 Thermo Fisher Scientific, Inc.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.6.5 SWOT analysis
8.4.7 Bayer AG
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.7.5 SWOT analysis
8.4.8 Merck & Co., Inc.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.8.5 SWOT analysis
8.4.9 Cook Medical LLC (Cook Group)
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Genea Biomedx
8.4.10.1 Company overview
8.4.10.2 Financial Performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 Progyny, Inc.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Services benchmarking
8.4.11.4 Strategic initiatives
8.4.12 Boston IVF
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 Ferring Pharmaceutical B.V.
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
Chapter 9 Recommendations
9.1 Key Insights

List of Tables

1. List of secondary sources
2. List of abbreviation
3. Clinical trial analysis
4. Comparison between the fresh and frozen donor treatment (U.S.)
5. Canadian law on ART
6. Status of public funding for IVF in Canada
7. Global disposable devices market estimates and forecast, 2016 - 2028 (USD Million)
8. Global culture media market estimates and forecast, 2016 - 2028 (USD Million)
9. Global capital equipment market estimates and forecast, 2016 - 2028 (USD Million)
10. Global fresh donor market estimates and forecast, 2016 - 2028 (USD Million)
11. Global frozen donor market estimates and forecast, 2016 - 2028 (USD Million)
12. Global fresh non-donor equipment market estimates and forecast, 2016 - 2028 (USD Million)
13. Global frozen non-donor market estimates and forecast, 2016 - 2028 (USD Million)
14. Global fertility clinics market estimates and forecast, 2016 - 2028 (USD Million)
15. Global hospitals & others setting market estimates and forecast, 2016 - 2028 (USD Million)
16. North America in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
17. North America in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
18. North America in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
19. North America in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
20. U.S. in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
21. U.S. in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
22. U.S. in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
23. U.S. in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
24. Europe in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
25. Europe in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
26. Europe in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
27. Europe in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
28. France in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
29. France in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
30. France in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
31. France in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
32. Germany in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
33. Germany in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
34. Germany in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
35. Germany in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
36. Italy in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
37. Italy in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
38. Italy in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
39. Italy in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
40. Spain in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
41. Spain in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
42. Spain in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
43. Spain in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
44. U.K. in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
45. U.K. in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
46. U.K. in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
47. U.K. in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
48. Belgium in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
49. Belgium in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
50. Belgium in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
51. Belgium in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
52. Netherlands in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
53. Netherlands in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
54. Netherlands in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
55. Netherlands in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
56. Switzerland in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
57. Switzerland in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
58. Switzerland in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
59. Switzerland in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
60. Asia Pacific in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
61. Asia Pacific in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
62. Asia Pacific in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
63. Asia Pacific in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
64. Japan in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
65. Japan in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
66. Japan in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
67. Japan in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
68. China in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
69. China in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
70. China in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
71. China in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
72. India in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
73. India in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
74. India in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
75. India in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
76. Latin America in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
77. Latin America in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
78. Latin America in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
79. Latin America in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
80. Brazil in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
81. Brazil in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
82. Brazil in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
83. Brazil in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
84. Mexico in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
85. Mexico in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
86. Mexico in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
87. Mexico in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
88. Middle East & Africa in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
89. Middle East & Africa in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
90. Middle East & Africa in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
91. Middle East & Africa in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)
92. South Africa in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Million)
93. South Africa in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Million)
94. South Africa in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Million)
95. South Africa in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Million)

List of Figures

1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Market research approaches
5. Supply-chain-based sizing & forecasting
6. QFD modeling for market share assessment
7. Market formulation & validation
8. In Vitro Fertilization (IVF) market summary, 2020 (USD Million)
9. In Vitro Fertilization (IVF) market segmentation
10. Penetration & growth prospect mapping
11. Market trends & outlook
12. Market driver relevance analysis (Current & future impact)
13. Semen sample imported in Brazil (Units)
14. Female age-based chance of conception
15. Market restraint relevance analysis (Current & future impact)
16. IVF market: Type movement analysis
17. IVF market type outlook: Key takeaways
18. Global IVF procedures market, by procedure type, 2016 - 2028 (USD Million)
19. Fresh nondonor market, 2016 - 2028 (USD Million)
20. Frozen nondonor market 2016 - 2028 (USD Million)
21. Fresh donor market 2016 - 2028 (USD Million)
22. Frozen donor market 2016 - 2028 (USD Million)
23. IVF market: End-use movement analysis
24. IVF market end-use outlook: Key takeaways
25. Fertility clinics market, 2016 - 2028 (USD Million)
26. Hospitals and other settings market, 2016 - 2028 (USD Million)
27. In Vitro Fertilization (IVF) market: Instrument movement analysis
28. IVF market Instrument outlook: Key takeaways
29. IVF instrument market, 2016 - 2028 (USD Million)
30. Culture media market, 2016 - 2028 (USD Million)
31. Disposable devices market, 2016 - 2028 (USD Million)
32. Capital equipment market, 2016 - 2028 (USD Million)
33. Regional outlook, 2020 & 2028
34. Regional market place: Key takeaways
35. North America IVF market, 2016 - 2028 (USD Million)
36. U.S. IVF market, 2016 - 2028 (USD Million)
37. Canada IVF market, 2016 - 2028 (USD Million)
38. Europe IVF market, 2016 - 2028 (USD Million)
39. France IVF market, 2016 - 2028 (USD Million)
40. Germany IVF market, 2016 - 2028 (USD Million)
41. Italy IVF market, 2016 - 2028 (USD Million)
42. Spain IVF market, 2016 - 2028 (USD Million)
43. U.K. IVF market, 2016 - 2028 (USD Million)
44. Belgium IVF market, 2016 - 2028 (USD Million)
45. Netherlands IVF market, 2016 - 2028 (USD Million)
46. Switzerland IVF market, 2016 - 2028 (USD Million)
47. Asia Pacific IVF market, 2016 - 2028 (USD Million)
48. Japan IVF market, 2016 - 2028 (USD Million)
49. China IVF market, 2016 - 2028 (USD Million)
50. India IVF market, 2016 - 2028 (USD Million)
51. Latin America IVF market, 2016 - 2028 (USD million)
52. Brazil IVF market, 2016 - 2028 (USD million)
53. Mexico IVF market, 2016 - 2028 (USD million)
54. MEA IVF market, 2016 - 2028 (USD Million)
55. South Africa IVF market, 2016 - 2028 (USD million)
56. Strategy framework
57. Strategy mapping
58. Company market position analysis

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の体外受精市場2021-2028:機器別(使い捨てデバイス、培地)、処置タイプ別(新鮮ドナー、凍結ドナー)、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆